688356 Jenkem Technology
- 56.33
- +1.64+3.00%
Jenkem Technology News
2024 THIRD QUARTER REPORT (CORRECTED)
Corrections to the 2024 Third Quarter Report
Announcement on the progress of the repurchase of shares through centralized bidding transactions
Jiankai Technology: CITIC Securities Co., Ltd.\'s verification opinion on the completion of some fund-raising projects of Beijing Jiankai Technology Co., Ltd. and the savings raised to permanently supplement working capital
Jiankai Technology: Announcement of Resolutions of the 10th Meeting of the Third Board of Directors
Jiankai Technology: Announcement on holding the results briefing for the third quarter of 2024
Jiankai Technology: Announcement on the completion of some fund-raising projects and permanently supplementing working capital with savings raised
Jiankai Technology: Third quarter report 2024
Jiankai Technology: Announcement of Resolutions of the Eighth Meeting of the Third Board of Supervisors
Announcement on holding the results briefing for the third quarter of 2024
Announcement on the settlement of some fund-raising projects and permanently replenishing working capital from savings raised
Third Quarter Report 2024
Announcement of Resolutions of the Eighth Meeting of the Third Board of Supervisors
CITIC Securities Co., Ltd.\'s verification opinion on the completion of some fund-raising projects of Beijing Jiankai Technology Co., Ltd. and the savings raised to permanently supplement working capital
Announcement of Resolutions of the 10th Meeting of the Third Board of Directors
Jiankai Technology: Announcement on the progress of share repurchases through centralized bidding transactions
Announcement on the progress of the repurchase of shares through centralized bidding transactions
Jiankai Technology: Announcement on Voluntary Disclosure of Polyethylene Glycol Irinotecan for the Treatment of Small Cell Lung Cancer Phase III Clinical Trials Completing the Enrollment of the First Case
Notice on Voluntary Disclosure of Polyethylene Glycol Irinotecan for the Treatment of Small Cell Lung Cancer Phase III Clinical Trials Completing the Enrollment of the First Case
Announcement on attending the 2024 Semi-Annual Science and Technology Innovation Board Special Group Results Briefing on Pharmaceuticals and Biological Products
Analysis
Price Target
No Data
No Data